Determining the value of endoscopic retrograde cholangiopancreatography in the management of patients with acute pancreatitis and related complications.

IF 3.8 3区医学 Q2 GASTROENTEROLOGY & HEPATOLOGY

Expert Review of Gastroenterology & Hepatology Pub Date : 2025-02-17 DOI:10.1080/17474124.2025.2464057

Sujani Yadlapati, Aditya Gutta, Evan L Fogel

{"title":"Determining the value of endoscopic retrograde cholangiopancreatography in the management of patients with acute pancreatitis and related complications.","authors":"Sujani Yadlapati, Aditya Gutta, Evan L Fogel","doi":"10.1080/17474124.2025.2464057","DOIUrl":null,"url":null,"abstract":"Introduction: Endoscopic retrograde cholangiopancreatography (ERCP) has evolved from a diagnostic to a therapeutic tool in acute pancreatitis management, largely due to the availability of less invasive diagnostic modalities such as endoscopic ultrasound (EUS) and magnetic resonance cholangiopancreatography (MRCP).Areas covered: This review explores the therapeutic applications of ERCP across various acute pancreatitis etiologies and its role in managing complications such as bile duct obstructions, pancreatic duct disruptions, and infected necrosis. The discussion highlights the procedure's expanding indications and its critical role in addressing complex cases.Expert opinion: ERCP remains central to the management of acute pancreatitis complications. As endoscopic techniques and devices continue to advance, its therapeutic scope is likely to grow. Performing ERCP for appropriate indications and optimizing its use is essential for minimizing risks and improving outcomes.","PeriodicalId":12257,"journal":{"name":"Expert Review of Gastroenterology & Hepatology","volume":" ","pages":"1-19"},"PeriodicalIF":3.8000,"publicationDate":"2025-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Gastroenterology & Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/17474124.2025.2464057","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: Endoscopic retrograde cholangiopancreatography (ERCP) has evolved from a diagnostic to a therapeutic tool in acute pancreatitis management, largely due to the availability of less invasive diagnostic modalities such as endoscopic ultrasound (EUS) and magnetic resonance cholangiopancreatography (MRCP).

Areas covered: This review explores the therapeutic applications of ERCP across various acute pancreatitis etiologies and its role in managing complications such as bile duct obstructions, pancreatic duct disruptions, and infected necrosis. The discussion highlights the procedure's expanding indications and its critical role in addressing complex cases.

Expert opinion: ERCP remains central to the management of acute pancreatitis complications. As endoscopic techniques and devices continue to advance, its therapeutic scope is likely to grow. Performing ERCP for appropriate indications and optimizing its use is essential for minimizing risks and improving outcomes.

查看原文本刊更多论文

内镜逆行胰胆管造影在急性胰腺炎及相关并发症治疗中的价值

导论：内窥镜逆行胰胆管造影（ERCP）已经从诊断发展成为急性胰腺炎治疗的一种工具，主要是由于内窥镜超声（EUS）和磁共振胰胆管造影（MRCP）等侵入性较小的诊断方式的可用性。涵盖领域：本综述探讨了ERCP在各种急性胰腺炎病因中的治疗应用及其在胆管阻塞、胰管中断和感染性坏死等并发症中的作用。讨论强调了该程序的扩展适应症及其在处理复杂病例中的关键作用。专家意见：ERCP仍然是急性胰腺炎并发症管理的核心。随着内窥镜技术和设备的不断进步，其治疗范围可能会扩大。为适当的适应症实施ERCP并优化其使用对于最小化风险和改善结果至关重要。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Expert Review of Gastroenterology & Hepatology GASTROENTEROLOGY & HEPATOLOGY-

CiteScore

6.80

自引率

2.60%

发文量

审稿时长

6-12 weeks

期刊介绍： The enormous health and economic burden of gastrointestinal disease worldwide warrants a sharp focus on the etiology, epidemiology, prevention, diagnosis, treatment and development of new therapies. By the end of the last century we had seen enormous advances, both in technologies to visualize disease and in curative therapies in areas such as gastric ulcer, with the advent first of the H2-antagonists and then the proton pump inhibitors - clear examples of how advances in medicine can massively benefit the patient. Nevertheless, specialists face ongoing challenges from a wide array of diseases of diverse etiology.